Nearly 400 non travel-related Zika infections will occur in Florida before the end of the summer, according to new projections by biostatisticians at the University of Florida and other institutions.
Amy Cantrell, PhD, a clinical associate professor of biostatistics, was selected by UF public health students for the 2016 Public Health Award for Faculty Excellence.
The United Nations’ interventions in the Sierra Leone Ebola outbreak led to a dramatic drop in the transmission of the disease, according to a study led by a University of Florida Health researcher.
An experimental vaccine combined with an innovative way of vaccinating people has resulted in an estimated 100 percent efficacy of the vaccine against the Ebola virus in West Africa — and the approach could establish a new way of responding to outbreaks of emerging pathogens, including the Zika virus.
The world’s largest outbreak of the Ebola virus has infected more than 28,000 people and killed more than 11,000 since March 2014 when the epidemic began spreading across West Africa. In July 2015 the World Health Organization announced a major development in the Ebola fight:
Nationally recognized researcher Dr. Fei Zou, has joined the University of Florida Department of Biostatistics, effective August 24, 2015. We welcome Dr. Zou from the University of North Carolina
We are pleased to announce that Dr. Susmita Datta has joined the University of Florida Department of Biostatistics as part of the university’s preeminence initiative in metabolomics. Dr. Datta comes to UF from the University of Louisville
Dr. Somnath Datta comes to the University of Florida from the University of Louisville under UF’s preeminent initiative in genomics, effective September 1, 2015. He was a Professor, Vice Chair, University Scholar
Qi An, a third year PhD student in Biostatistics, has accepted a 12-week clinical statistics summer internship with Bayer HealthCare in Whippany, New Jersey. As an intern within the Clinical Statistics US Department, she will gain a direct view into research and development at Bayer and witness how clinical…
Implementing a vaccine trial during an epidemic can be difficult, particularly in countries with poor transportation, limited vaccine supplies and difficulty predicting how widespread a disease may become — conditions such as those in West Africa during the recent Ebola outbreak. Now, a University of Florida Health researcher with…
